Alcohol withdrawal can be life-threatening. If you drink heavily and may be dependent, seek medical guidance before stopping; a commercial NAD+ infusion is not a substitute for a withdrawal assessment or emergency care.
NAD is involved in cellular metabolism, including pathways discussed in alcohol research. That biological connection does not establish that an NAD drip prevents withdrawal seizures, treats alcohol use disorder, or prevents relapse.
Choose appropriate medical withdrawal care and ongoing treatment. NAD infusion research does not establish those protections.
What does “detox” mean in this context?
A wellness advertisement may use “detox” to mean feeling refreshed. Medical alcohol withdrawal is a different problem that can require monitoring and treatment. NIAAA guidance explains that the needed setting depends on risk and symptoms. A package title or an IV chair does not tell you whether a service can manage dangerous withdrawal.
What did the often-cited NAD infusion pilot study measure?
The 2019 IV NAD pilot measured changes in NAD-related blood and urine metabolites during an infusion in healthy men. It was not a controlled trial of alcohol withdrawal, craving reduction, seizure prevention, or sustained recovery. A paper’s discussion of possible applications should not be confused with an outcome its participants were actually studied for.
How should you evaluate a clinic’s claim?
Ask for the original trial, the participants’ diagnosis, the comparison treatment, and the outcome measured. A testimonial from someone receiving several kinds of care cannot isolate the contribution of NAD. Also ask who assesses withdrawal risk, what medical monitoring is provided, and how urgent transfer is arranged. Choosing a clinic provides additional questions, but a wellness directory does not verify addiction-treatment capability.
Withdrawal care and recovery care are different stages
Getting safely through withdrawal does not by itself address the longer course of alcohol use disorder. NIAAA describes treatment options that can include medicines, behavioral care, and ongoing support. Discuss those options with a qualified professional. Avoid replacing them with a prepaid infusion series on the promise that a metabolic “reset” will remove the need for follow-up.
An infusion also has its own safety questions
The FDA’s sterile-compounding notice discusses reactions reported with injectable NAD products and concerns about unsuitable ingredients. That issue is separate from whether NAD has a useful role in alcohol treatment. Both effectiveness and preparation quality matter; addressing one does not answer the other. See compounded NAD safety.
When urgent help takes priority
Seizures, hallucinations, severe confusion, or rapidly worsening symptoms during possible withdrawal require urgent medical care; call 911 for an emergency in the United States. Do not wait for an infusion appointment or attempt a home NAD protocol. For non-emergency treatment planning, ask a healthcare professional about an appropriate withdrawal setting and continuing care, with the full drinking history and medication list available.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- NIAAA: alcohol use disorder, withdrawal, and recovery Withdrawal can be life-threatening and needs risk-appropriate medical care; ongoing AUD treatment is a separate need.
- Grant et al. (2019): NAD+ infusion metabolome pilot Small human IV study; metabolic observations do not prove longevity or everyday benefits.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.